p-Hydroxyphenethyl trans-ferulate
Based on 1 Customer Validation
p-Hydroxyphenethyl trans-ferulate is an α-glucosidase inhibitor with an IC50 of 19.24 µM against yeast α-glucosidase, and it also possesses antioxidant and anti-inflammatory activities. p-Hydroxyphenethyl trans-ferulate exhibits weak inhibitory activity against rat lens aldose reductase, competitively binds to the 5-HT7 receptor, and inhibits radioligand binding. p-Hydroxyphenethyl trans-ferulate has DPPH radical scavenging effects, exerts anti-inflammatory activity by inhibiting TPA (HY-18739)-induced mouse ear edema, inhibits advanced glycation end product formation, and demonstrates cancer preventive activity as well as serotonergic activity. p-Hydroxyphenethyl trans-ferulate can be used in research related to diabetes, inflammation, and cancer.
For research use only. We do not sell to patients.
- Purity : 99.68%
- CAS No.: 84873-15-4
- Formula: C18H18O5
- Molecular Weight:314.33
-
Storage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-B0025
VogliboseGlucosidase Inhibitor -
HY-N0466
Rebaudioside Aα-Glucosidase Inhibitor -
HY-W009417
Cedryl acetateα-glucosidase Inhibitor -
HY-N4195
Resveratrolosideα-Glucosidase Inhibitior -
HY-N0374
Licochalcone Cα-Glucosidase Inhibitor -
HY-N2574
GitogeninGlucosidase Inhibitor -
HY-N2025
Oroxin APartial PPARγ Agonist -
HY-N1510
Kaempferol 3-O-gentiobiosideFlavonoid -
HY-W005598
2-Hydroxyquinolineα-Glucosidase/α-Amylase Inhibitor -
HY-154823
Gcase activator 2GCase Inhibitor -
HY-N7626
EleutherolAntifungal Agent -
HY-125713
Ganoderic acid YGlucosidase Inhibitor
All 5-HT Receptor Isoforms
More
Biological Activity
Description
|
Aldose reductase 191.91 μM (IC50) |
5-HT7 Receptor 47.6 μM (IC50) |
α‑glucosidase 19.24 μM (IC50, Yeast) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | IC50 |
47.6 μM
Compound: 5
|
Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells by liquid scintillation counting
Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells by liquid scintillation counting
|
[PMID: 16643021] |
| Erythrocyte | IC50 |
0.66 mM
Compound: 26
|
Anticomplement activity in sheep erythrocytes assessed as concentration required for 50% hemolytic inhibition by classic pathway pretreated for 10 mins with guinea pig serum followed by erythrocyte addition measured after 30 mins by spectrophotometeric me
Anticomplement activity in sheep erythrocytes assessed as concentration required for 50% hemolytic inhibition by classic pathway pretreated for 10 mins with guinea pig serum followed by erythrocyte addition measured after 30 mins by spectrophotometeric me
|
[PMID: 29631958] |
| Erythrocyte | IC50 |
1.01 mM
Compound: 26
|
Anticomplement activity in rabbit erythrocytes assessed as concentration required for 50% hemolytic inhibition by alternative pathway pretreated for 10 mins with normal human serum followed by erythrocyte addition measured after 30 mins by spectrophotomet
Anticomplement activity in rabbit erythrocytes assessed as concentration required for 50% hemolytic inhibition by alternative pathway pretreated for 10 mins with normal human serum followed by erythrocyte addition measured after 30 mins by spectrophotomet
|
[PMID: 29631958] |
| HT-1080 | ED50 |
47.1 μg/mL
Compound: f
|
Antiproliferative activity against human HT1080 cells after 4 days by MTT assay
Antiproliferative activity against human HT1080 cells after 4 days by MTT assay
|
[PMID: 11374950] |
| MDA-MB-231 | IC50 |
44.3 μM
Compound: 5; Tyrosol ferulate
|
Antimigratory activity against human MDA-MB-231 cells expressing c-MET assessed as inhibition of HGF-induced cell migration incubated for 24 hrs by Giemsa staining based wound healing assay
Antimigratory activity against human MDA-MB-231 cells expressing c-MET assessed as inhibition of HGF-induced cell migration incubated for 24 hrs by Giemsa staining based wound healing assay
|
[PMID: 27258622] |
| MDA-MB-231 | IC50 |
87.6 μM
Compound: 5; Tyrosol ferulate
|
Antiproliferative activity against human MDA-MB-231 cells expressing c-MET assessed as inhibition of HGF-induced cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells expressing c-MET assessed as inhibition of HGF-induced cell growth incubated for 72 hrs by MTT assay
|
[PMID: 27258622] |
| MDA-MB-468 | IC50 |
95.5 μM
Compound: 5; Tyrosol ferulate
|
Antiproliferative activity against human MDA-MB-468 cells expressing c-MET assessed as inhibition of HGF-induced cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-468 cells expressing c-MET assessed as inhibition of HGF-induced cell growth incubated for 72 hrs by MTT assay
|
[PMID: 27258622] |
In Vitro
p-Hydroxyphenethyl trans-ferulate (100 µM; 10 min) shows no inhibitory effect on mammalian α-glucosidase[3].
p-Hydroxyphenethyl trans-ferulate (1 μM-3 mM; 24 h) inhibits the formation of pentosidine-like AGEs in the cell-free BSA/ᴅ-ribose assay, with an IC50 of 150 μM[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NIH (male, 25-30 g)[3]
-
Dosage:1 µmol/ear
-
Administration:topical application to the ear; single dose
-
Result:Edema was 7.40 mg.
Inhibition of TPA-induced mouse ear edema was 48.49%.
Chemical Information
-
CAS No. 84873-15-4
-
Appearance Solid
-
Molecular Weight 314.33
-
Formula C18H18O5
-
Color White to off-white
-
SMILES
OC(C=C1)=CC=C1CCOC(/C=C/C2=CC(OC)=C(O)C=C2)=O
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (318.14 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.1814 mL | 15.9069 mL | 31.8137 mL | 79.5343 mL |
| 5 mM | 0.6363 mL | 3.1814 mL | 6.3627 mL | 15.9069 mL | |
| 10 mM | 0.3181 mL | 1.5907 mL | 3.1814 mL | 7.9534 mL | |
| 15 mM | 0.2121 mL | 1.0605 mL | 2.1209 mL | 5.3023 mL | |
| 20 mM | 0.1591 mL | 0.7953 mL | 1.5907 mL | 3.9767 mL | |
| 25 mM | 0.1273 mL | 0.6363 mL | 1.2725 mL | 3.1814 mL | |
| 30 mM | 0.1060 mL | 0.5302 mL | 1.0605 mL | 2.6511 mL | |
| 40 mM | 0.0795 mL | 0.3977 mL | 0.7953 mL | 1.9884 mL | |
| 50 mM | 0.0636 mL | 0.3181 mL | 0.6363 mL | 1.5907 mL | |
| 60 mM | 0.0530 mL | 0.2651 mL | 0.5302 mL | 1.3256 mL | |
| 80 mM | 0.0398 mL | 0.1988 mL | 0.3977 mL | 0.9942 mL | |
| 100 mM | 0.0318 mL | 0.1591 mL | 0.3181 mL | 0.7953 mL |
p-Hydroxyphenethyl trans-ferulate Related Classifications
HY-N3078 Related Classifications
Powered by Bioz
Keywords
- p-Hydroxyphenethyl trans-ferulate
- 84873-15-4
- Glycosidase
- Aldose Reductase
- 5-HT Receptor
- Free Radical Scavengers
- 5-HT7 receptor
- DPPH free radical scavenging
- advanced glycation endproducts formation inhibition
- aldose reductase inhibitor
- anti-inflammatory activity
- cancer preventive activity
- carbohydrate-hydrolyzing enzyme inhibition
- polyol pathway
- serotonergic activity
- α-glucosidase inhibitor
- Inhibitor
- inhibitor
- inhibit